Our Pricing

Wegovy Price Trends in the UK: What You Need to Know

Published on: June 03, 2026

Concerns about a wegovy price increase uk 2025 have prompted many patients to seek transparent pricing from registered online pharmacies. At Cured Pharmacy, Wegovy (semaglutide) remains available from £79.00 with £20 off available today—offering predictable costs and UK prescriber support throughout your weight loss journey.

Is Wegovy Going Up in Price in the UK?

Weight loss medication pricing in the UK can fluctuate due to supply chain factors, manufacturer adjustments, and market demand. Whilst some pharmacies have adjusted their Wegovy pricing in recent months, Cured Pharmacy maintains competitive rates with transparent upfront costs—currently from £79.00 per pen, subject to your prescribed dose.

Unlike traditional high street pharmacies where pricing may vary without notice, registered online pharmacies like Cured Pharmacy display all costs before your clinical consultation. This transparency helps you plan your treatment budget effectively, particularly for medications requiring ongoing use over several months [1].

How Wegovy (Semaglutide) Works for Weight Loss

Wegovy contains semaglutide, a GLP-1 receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities [1]. Semaglutide mimics a natural gut hormone that regulates appetite and food intake, helping patients feel fuller for longer periods.

The landmark STEP clinical trial programme demonstrated that patients using semaglutide 2.4mg weekly achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [2]. These results positioned Wegovy as one of the most effective pharmaceutical weight loss interventions available through UK prescribers.

Weekly Injection Schedule

Wegovy is administered once weekly via a pre-filled injection pen. Your UK prescriber will start you on a lower dose (0.25mg) and gradually increase over 16-20 weeks to the maintenance dose of 2.4mg weekly. This dose escalation helps minimise gastrointestinal side effects whilst your body adjusts to the medication [1].

Wegovy vs Mounjaro: Clinical Efficacy Comparison

Both Wegovy (semaglutide) and Mounjaro (tirzepatide) are injectable medications licensed in the UK for weight management, but they work through different mechanisms. Whilst Wegovy activates GLP-1 receptors only, Mounjaro is a dual GIP/GLP-1 receptor agonist, engaging two complementary pathways that regulate appetite and metabolism [3].

Head-to-head trial data suggests tirzepatide may produce greater average weight loss than semaglutide. In the SURPASS-2 trial, patients on tirzepatide 15mg achieved up to 22.5% body weight reduction compared to approximately 15% with semaglutide in separate studies [3][4]. However, individual response varies considerably, and your UK prescriber will recommend the most appropriate option based on your medical history, tolerance, and treatment goals.

Cost Considerations Between Treatments

Wegovy typically represents a more accessible starting point for many patients due to lower initial costs, whilst Mounjaro may offer enhanced efficacy for those who can accommodate higher treatment expenses. Both medications require ongoing use to maintain weight loss benefits, making long-term affordability an important consideration during your consultation.

Getting Wegovy Through Cured Pharmacy

All Wegovy prescriptions at Cured Pharmacy require completion of a free online clinical assessment reviewed by UK-registered prescribers. This typically takes under three minutes and covers your medical history, current medications, weight loss goals, and any contraindications that might affect suitability [1].

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all clinical pathways to ensure every prescription meets MHRA safety standards and GPhC regulatory requirements. Once approved, your medication is dispensed from our UK-registered pharmacy (GPhC 9012511) in discreet packaging with next-day delivery options available across the UK.

What Happens During Your Consultation

Your online assessment will ask about your current BMI, previous weight loss attempts, existing health conditions (particularly thyroid disorders, pancreatitis history, or diabetic retinopathy), and any medications you're currently taking. UK prescribers cannot approve Wegovy for patients with certain conditions, including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [1].

Managing Side Effects and Treatment Expectations

The most common side effects reported with Wegovy include nausea, diarrhoea, vomiting, constipation, and abdominal discomfort, particularly during the initial dose escalation phase [1][2]. These gastrointestinal symptoms typically diminish as your body adjusts to the medication over several weeks.

Clinical trial data shows that most patients who discontinue Wegovy do so within the first 20 weeks due to tolerability concerns [2]. Starting with a low dose and following the gradual escalation schedule prescribed by your UK clinician significantly reduces the likelihood of severe side effects. Eating smaller meals, avoiding high-fat foods, and staying well-hydrated can further improve tolerance.

It's important to maintain realistic expectations: Wegovy is not a standalone solution but works most effectively when combined with a reduced-calorie diet and increased physical activity. Patients who engage with comprehensive lifestyle modifications alongside medication tend to achieve better long-term outcomes than those relying on pharmacotherapy alone [2].

Alternative Weight Loss Treatments Available

If Wegovy pricing or clinical suitability presents challenges, several alternative treatments are available through Cured Pharmacy. Saxenda (liraglutide) is a daily injectable GLP-1 medication that may suit patients preferring more frequent dosing with potentially lower per-injection costs. Orlistat-based treatments work through a completely different mechanism by reducing dietary fat absorption in the gut, making them appropriate for patients who cannot tolerate GLP-1 medications.

For patients seeking maximum efficacy and willing to invest in newer therapies, Mounjaro (tirzepatide) represents the latest advancement in weight management pharmacotherapy. Your UK prescriber will discuss all suitable options during your consultation, considering your medical history, budget constraints, and treatment preferences to identify the most appropriate pathway for your circumstances.

Scientific References

1. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Novo Nordisk Limited. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
4. Frías, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to lifestyle modifications alongside pharmacotherapy.